nach oben

Erschienen in:

2020 | OriginalPaper | Buchkapitel

6. Klinik mikroskopischer Kolitiden und eosinophiler Erkrankungen des Gastrointestinaltraktes

verfasst von : Ahmed Madisch, Stephan Miehlke

Erschienen in: Chronisch-entzündliche Darmerkrankungen

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die mikroskopische Kolitis mit dem klinischen Leitsymptom der chronisch-wäßrigen Diarrhö zählt zu den chronisch-entzündlichen Darmerkrankungen und umfasst die beiden Entitäten der kollagenen und lymphozytären Kolitis. Da die Endoskopie bei Patienten mit mikroskopischer Kolitis in der Regel unauffällig ist, gelingt die Abgrenzung zum Reizdarmsyndrom und somit die Diagnosesicherung nur anhand der Histopathologie der entnommenen Stufenbiopsien. Die eosinophilen Erkrankungen des Gastrointestinaltraktes können angesichts unspezifischer bildgebender Befunde nur über eine Biopsieentnahme in den entsprechenden Abschnitten des Gastrointestinaltraktes diagnostiziert werden.

Agnarsdottir M, Gunnlaugsson O, Orvar KB et al (2002) Collagenous and lymphocytic colitis in Iceland. Dig Dis Sci 47:1122–1128PubMed

Aigner T, Neureiter D, Muller S, Kuspert G, Belke J, Kirchner T (1997) Extracellular matrix composition and gene expression in collagenous colitis. Gastroenterology 113:136–143PubMed

Bjørnbak C, Engel PJ, Nielsen PL, Munck LK (2011) Microscopic colitis: clinical findings, topography and persistence of histopathological subgroups. Aliment Pharmacol Ther 34:1225–1234PubMed

Bogomoletz WV (1994) Collagenous, microscopic and lymphocytic colitis. An evolving concept. Virchows Arch 6:573–579

Bohr J, Tysk C, Eriksson S, Jarnerot G (1995) Collagenous colitis in Orebro, Sweden, an epidemiological study 1984–1993. Gut 37:394–397PubMedPubMedCentral

Burgel N, Bojarski C, Mankertz J, Zeitz M, Fromm M, Schulzke JD (2002) Mechnisms of diarrhea in collagenous colitis. Gastroenterology 123:433–443PubMed

Burke KE, Ananthakrishnan AN, Lochhead P, Liu SP, Olen O, Ludvigsson JF, Richter JM, Tworoger SS, Chan AT, Khalili H (2018) Identification of menopausal and reproductive risk factors for microscopic colitis – results from the Nurses’ Health Study. Gastroenterology 155(6):1764–1775, pii: S0016-5085(18)34894-7PubMedPubMedCentral

Cotter TG, Binder M, Loftus EV Jr, Abboud R, McNally MA, Smyrk TC, Tremaine WJ, Sandborn WJ, Pardi DS (2018) Development of a microscopic colitis disease activity index: a prospective cohort study. Gut 67:441–446PubMed

Fernandez-Banares F, Salas A, Forne M, Esteve M, Espinos J, Viver JM (1999) Incidence of collagenous and lymphocytic colitis: a 5-year population-based study. Am J Gastroenterol 94:418–423PubMed

Fernandez-Banares F, Esteve M, Espinos JC, Rosinach M, Forne M, Salas A, Viver JM (2007) Drug consumption and the risk of microscopic colitis. Am J Gastroenterol 102:324–330PubMed

Fernández-Bañares F, de Sousa MR, Salas A, Beltrán B, Piqueras M, Iglesias E, Gisbert JP, Lobo B, Puig-Diví V, García-Planella E, Ordás I, Andreu M, Calvo M, Montoro M, Esteve M, Viver JM, RECOMINA Project, GETECCU (Grupo Español de Enfermedades de Crohn y Colitis Ulcerosa) (2013) Impact of current smoking on the clinical course of microscopic colitis. Inflamm Bowel Dis 19:1470–1476PubMed

Fumery M, Kohut M, Gower-Rousseau C, Duhamel A, Brazier F, Thelu F, Nagorniewicz F, Lamarche F, Nguyen-Khac E, Sabbagh C, Loreau J, Colombel JF, Savoye G, Chatelain D, Dupas JL, On behalf on the Somme MC group.; EPIMAD group (2017) Incidence, clinical presentation, and associated factors of microscopic colitis in Northern France: a population-based study. Dig Dis Sci 62(6):1571–1579PubMed

Hjortswang C, Tysk C, Bohr J, Benoni C, Kilander A, Larsson L et al (2009) Defining clinical criteria for clinical remission and disease activity in collagenous colitis. Inflamm Bowel Dis 15:1875–1881PubMed

Kagalwalla AF, Sentongo TA, Ritz S et al (2006) Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol 4:1097–1102PubMed

Kamp EJ, Kane JS, Ford AC (2016) Irritable bowel syndrome and microscopic colitis. A systematic review and meta-analysis. Clin Gastroenterol Hepatol 14:659–668

Keely S, Walker MM, Marks E, Talley NJ (2015) Immune dysregulation in the functional gastrointestinal disorders. Eur J Clin Invest 45:1350–1359PubMed

Langner C, Aust D, Ensari A, Villanacci V, Becheanu G, Miehlke S, Geboes K, Münch A, Working Group of Digestive Diseases of the European Society of Pathology (ESP) and the European Microscopic Colitis Group (EMCG) (2015) Histology of microscopic colitis-review with a practical approach for pathologists. Histopathology 66:613–626PubMed

Lazenby AJ, Yardley JH, GiardielloI FM, Jessurun J, Bayless TM (1989) Lymphocytic (microscopic) colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol 20:18–28PubMed

Liacouras CA, Furuta GT, Hirano I et al (2011) Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 128:3–20.e6PubMed

Lindstrom CG (1976) Collagenous colitis with watery diarrhoea a new entity? Pathol Eur 11:87–93PubMed

Madisch A, Bethke B, Morgner A, Heymer P, Bästlein E, Stolte M, Miehlke S (2005a) Is there an association of microscopic colitis and irritable bowel syndrome? A subgroup analysis of placebo-controlled trials. World J Gastroenterol 11:6409PubMedPubMedCentral

Madisch A, Heymer P, Voss C, Wigginhaus B, Bästlein E, Bayerdörffer E, Meier E, Schimming W, Bethke B, Stolte M, Miehlke S (2005b) Oral Budesonide therapy improves quality of life in patients with collagenous colitis – results of placebo-controlled, multicenter trial. Int J Colorectal Dis 20:312–316PubMed

Madisch A, Miehlke S, Lindner M, Bethke B, Stolte M (2006a) Clinical course of collagenous colitis over a period of 10 years. Z Gastroenterol 44:971–974PubMed

Madisch A, Morgner A, Henker C, Bethke B, Barretton B, Stolte M, Miehlke S (2006b) The SIBDQ is more suitable than SF-36 to measure improvement of quality of life in patients with collagenous colitis treated with budesonide. Gut 55(Suppl V):A127

Madisch A, Miehlke S, Bartosch F, Bethke B, Stolte M (2014) Microscopic colitis: clinical presentation, treatment and outcome of 494 patients. Z Gastroenterol 52:1062–1065PubMed

Mansoor E, Saleh MA, Cooper GS (2017) Prevalence of eosinophilic gastroenteritis and colitis in a population-based study, from 2012 to 2017. Clin Gastroenterol Hepatol 15:1733–1741PubMed

Marlicz W, Skonieczna-Żydecka K, Yung DE, Loniewski I, Koulaouzidis A (2017) Endoscopic findings and colonic perforation in microscopic colitis: a systematic review. Dig Liver Dis 49:1073–1085PubMed

Mellander MR, Ekbom A, Hultcrantz R, Löfberg R, Öst Å, Björk J (2016) Microscopic colitis: a descriptive clinical cohort study of 795 patients with collagenous and lymphocytic colitis. Scand J Gastroenterol 51:556–562PubMed

Miehlke S, Aust D, Madisch A (2013) Microscopic colitis – new insights relevant to clinical practice. Z Gastroenterol 51:1389–1394PubMed

Münch A, Aust D, Bohr J, Bonderup O, Fernández Bañares F, Hjortswang H, Madisch A, Munck LK, Ström M, Tysk C, Miehlke S (2012) Microscopic colitis: current status, present and future challenges. J Crohn’s Colitis. https://doi.org/10.1016/j.crohns.2012.05.014CrossRef

Münch A, Tysk C, Bohr J, Madisch A, Bonderup OK, Mohrbacher R, Mueller R, Greinwald R, Ström M, Miehlke S (2015) Smoking status influences clinical outcome in collagenous colitis. J Crohns Colitis. pii: jjv235 (Epub ahead of print)

Okpara N, Aswad B, Baffy G (2009) Eosinophilic colitis. World J Gastroenterol 15:2975–2979PubMedPubMedCentral

Olesen M, Eriksson S, Bohr J, Jarnerot G, Tysk C (2004) Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993–1998. Gut 53:346–350PubMedPubMedCentral

Pardi DS, Kelly CP (2011) Microscopic colitis. Gastroenterology 140:1155–1165PubMed

Pardi DS, Miehlke S (2010) Mikroskopische Kolitis. Clinical update on inflammatory disorders of the gastrointestinal tract. Front Gastrointest Res 26:135–145

Read NW, Krejs GJ, Read MG, Santa Ana CA, Morawski SG, Fordtran JS (1980) Chronic diarrhea of unknown origin. Gastroenterology 76:264–271

Ridell RH, Tanaka M, Mazzoleni G (1992) Non-steroidal anti-inflammatory drugs as a possible cause of collagenous colitis: a case-control study. Gut 33:683–686

Rothenberg ME (2004) Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 113:11–28PubMed

Tong J, Zheng Q, Zhang C, Lo R, Shen J, Ran Z (2015) Incidence, prevalence, and temporal trends of microscopic colitis: a systematic review and meta-analysis. Am J Gastroenterol 110:265–276 (Erratum in: Am J Gastroenterol 2015;110:1121)PubMed

Turner KO, Sinkre RA, Neumann WL, Genta RM (2017) Primary colonic eosinophilia and eosinophilic colitis in adults. Am J Surg Pathol 41:225–233PubMed

Ung KA, Gillberg L, Kilander A, Abrahamsson H (2000) Role of bile acids and bile acid binding agents in patients with collagenous colitis. Gut 46:170–175PubMedPubMedCentral

Ung KA, Kilander A, Willen R, Abrahamsson H (2002) Role of bile acids in lymphocytic colitis. Hepatogastroenterology 49:432–437PubMed

Verhaegh BP, Jonkers DM, Driessen A, Zeegers MP, Keszthelyi D, Masclee AA, Pierik MJ (2015) Incidence of microscopic colitis in the Netherlands. A nationwide population-based study from 2000 to 2012. Dig Liver Dis 47:30–36PubMed

Verhaegh BPM et al (2016a) High risk of drug‐induced microscopic colitis with concomitant use of NSAIDs and proton pump inhibitors. Aliment Pharmacol Ther 43(9):1004–1013. https://doi.org/10.1111/apt.13583CrossRefPubMed

Verhaegh BP, de Vries F, Masclee AA, Keshavarzian A, de Boer A, Souverein PC, Pierik MJ, Jonkers DM (2016b) High risk of drug-induced microscopic colitis with concomitant use of NSAIDs and proton pump inhibitors. Aliment Pharmacol Ther 43:1004–1013PubMed

Vigren L, Sjöberg K, Benoni C, Tysk C, Bohr J, Kilander A, Larsson L, Ström M, Hjortswang H (2011) Is smoking a risk factor for collagenous colitis? Scand J Gastroenterol 46:1334–1339PubMed

Walker MM (2016) Inflammation, genetics, dysbiosis, and the environment: new paradigms for diagnosis in complex chronic gut syndromes. J Clin Gastroenterol 50(suppl 1):S4–S5

Walker MM, Potter M, Talley NJ (2018) Eosinophilic gastroenteritis and other eosinophilic gut diseases distal to the oesophagus. Lancet Gastroenterol Hepatol 3:271–280

Westerlind H, Mellander MR, Bresso F, Munch A, Bonfiglio F, Assadi G, Rafter J, Hübenthal M, Lieb W, Källberg H, Brynedal B, Padyukov L, Halfvarson J, Törkvist L, Bjork J, Andreasson A, Agreus L, Almer S, Miehlke S, Madisch A, Ohlsson B, Löfberg R, Hultcrantz R, Franke A, D’Amato M (2015) Dense genotyping of immune-related loci identifies HLA variants associated with increased risk of collagenous colitis. Gut. https://doi.org/10.1136/gutjnl-2015-309934 (Epub ahead of print)CrossRefPubMed

Yantiss RK (2015) Eosinophils in the GI tract: how many is too many and what do they mean? Mod Pathol 28(suppl 1):S7–S21PubMed

Yen EF, Pokhrel B, Du H, Nwe S, Bianchi L, Witt B, Hall C (2012) Current and past cigarette smoking significantly increase risk for microscopic colitis. Inflamm Bowel Dis 18:1835–1841PubMed

Zhang M, Li Y (2017) Eosinophilic gastroenteritis: a state-of-the-art review. Gastroenterol Hepatol 32:64–72

Titel: Klinik mikroskopischer Kolitiden und eosinophiler Erkrankungen des Gastrointestinaltraktes
verfasst von: Ahmed Madisch
Stephan Miehlke
Verlag: Springer Berlin Heidelberg
Buch: Chronisch-entzündliche Darmerkrankungen
Print ISBN: 978-3-662-59103-1

Electronic ISBN: 978-3-662-59104-8

Copyright-Jahr: 2020
DOI: https://doi.org/10.1007/978-3-662-59104-8_6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

6. Klinik mikroskopischer Kolitiden und eosinophiler Erkrankungen des Gastrointestinaltraktes

Zusammenfassung

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin